Baku 23° C
France begins trials of new COVID vaccine
Other countries
- 25 February, 2021
- 06:11
Add Report.az to preferred Google sources
Stay up to date with the top news!
French biotechnology company Xenothera has begun clinical trials of its coronavirus vaccine, Report informs with reference to TASS.
The vaccine is named Xav-19.
The vaccine testing program follows Polycor standards, one of 15 types of clinical trials of drugs approved by the French medical authorities. The trial will be carried out in 40 hospitals in the country, coordinated by the University Hospital of Nantes.
The drug will be tested on 400 volunteer patients. Currently, 67 patients from 21 hospitals are participating in the trial.
The tests are supposed to determine the level of vaccine effectiveness with great accuracy.
Author
Fransada yeni koronavirus peyvəndinin sınaqlarına başlanılır
Во Франции начинаются испытания новой вакцины от COVID-19
Latest News
17:39
ECO transport ministers to gather in Astana to approve long-term strategy
Infrastructure
17:34
US Embassy congratulates Azerbaijan's judokas on World Championship success
Individual sports
17:29
Azerbaijan's gasoline and diesel retail sales rise 4% in January-September
Energy
17:26
Baku urges citizens to avoid dangerous Black Sea routes after ship attack
Foreign policy
17:25
Sadyr Japarov to visit Azerbaijan on October 14
Foreign policy
17:18
MFA: All eight Azerbaijani nationals aboard drone-attacked ship in Black Sea rescued
Other countries
17:14
Expert says school uniforms in Azerbaijan promote equality, discipline and responsibility
Education and science
17:03
Azerbaijan fell short of its OPEC+ quota by 103,000 bpd in August
Energy
17:02
OPEC: Oil exports via BTC pipeline rise 8% in August
Energy